SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001618835-20-000242
Filing Date
2020-11-09
Accepted
2020-11-09 16:29:34
Documents
75
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q evfm-20200930.htm   iXBRL 10-Q 1703669
2 EX-10.1 amendmentno1toarlicens.htm EX-10.1 30769
3 EX-31.1 evfm-9302020ex311.htm EX-31.1 19737
4 EX-31.2 evfm-9302020ex312.htm EX-31.2 19649
5 EX-32.1 evfm-9302020ex321.htm EX-32.1 10904
  Complete submission text file 0001618835-20-000242.txt   8731992

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20200930.xsd EX-101.SCH 66469
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evfm-20200930_cal.xml EX-101.CAL 82808
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20200930_def.xml EX-101.DEF 388665
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20200930_lab.xml EX-101.LAB 746387
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20200930_pre.xml EX-101.PRE 515128
11 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20200930_htm.xml XML 1501922
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36754 | Film No.: 201298119
SIC: 2834 Pharmaceutical Preparations